
Soligenix, Inc (NASDAQ: SNGX) CEO Interview Update
About: Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. We have two areas of focus: 1) a specialized biotherapeutics segment dedicated […]